Kara D. Forinash

RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer

Ronil A. Patel, Kara D. Forinash, Roberta Pireddu et al. · Cancer Research · 2012 · 148 citations

Life Sciences, Oncology, Pharmacology +14

Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice

Maria E. Balasis, Kara D. Forinash, Y. Ann Chen et al. · Clinical Cancer Research · 2011 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16

Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)

Roberta Pireddu, Kara D. Forinash, Nan N. Sun et al. · MedChemComm · 2012 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours

Xiaolei Zhang, Mark A. T. Blaskovich, Kara D. Forinash et al. · British Journal of Cancer · 2014 · 29 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation

Savitha S. Sharma, Le Ma, Tapan Bagui et al. · Oncogene · 2011 · 23 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17